期刊文献+

多囊卵巢综合征患者miRNAs差异表达的研究进展 被引量:1

ADVANCES IN DIFFERENTIAL EXPRESSION OF miRNAs IN POLYCYSTIC OVARY SYNDROME
下载PDF
导出
摘要 微小核糖核酸(microRNA,miRNAs)是短链非编码RNA,在组织发育和分化过程中对转录后基因表达的调节至关重要。它们参与多种生物调节,并且在女性生殖系统参与卵母细胞成熟和卵泡发育,尤其在多囊卵巢综合征(polycystic ovary syndrome,PCOS)中观察到了miRNAs水平的改变。近年来在多囊卵巢综合征患者的颗粒细胞、卵泡液以及外周血中均发现miRNAs有差异性表达,推测它可能是一种潜在的生物标志物,并可能成为诊断和治疗多囊卵巢综合征的新的靶点。本文就miRNAs与多囊卵巢综合征关系的最新研究进展进行综述,并探讨其在多囊卵巢综合征的发病机制以及临床诊断中的潜在作用。 MicroRNA are short non-coding RNAs that are critical for the regulation of post-transcriptional gene expression during tissue development and differentiation.They are involved in a variety of biological regulation and are involved in oocyte maturation and follicle development in the female reproductive system.In particular,altered miRNAs levels were observed in polycystic ovary syndrome(PCOS).In recent years,miRNA has been found to be differentially expressed in granulosa cells,follicular fluid and peripheral blood of PCOS patients,which is speculated to be a potential biomarker and a new therapeutic target for the diagnosis and treatment of PCOS.In this review,the recent research progress on the relationship between miRNAs and PCOS is reviewed,and the potential role of mirnas in the pathogenesis and clinical diagnosis of PCOS is discussed.
作者 原源 陈秀娟 杜琛 YUAN Yuan;CHEN Xiujuan;DU Chen(Center for Reproductive Medicine,The Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China)
出处 《内蒙古医科大学学报》 2023年第5期548-551,共4页 Journal of Inner Mongolia Medical University
基金 内蒙古自治区科技计划项目(2022YFSH0067) 内蒙古自治区卫生健康科技计划项目(202202159) 内蒙古医科大学面上项目(YKD2022MS017) 内蒙古自治区“草原英才”工程青年创新人才项目(2022) 内蒙古自治区“十四五”规划课题项目(NGJGH2022003)
关键词 微小RNA 多囊卵巢综合征 颗粒细胞 卵泡液 胰岛素抵抗 MicroRNA PCOS Granulosa cells Follicular fluid Insulin resistance
  • 相关文献

参考文献4

二级参考文献49

  • 1Diamanti-Kandarakis E. Polycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med 2008; lO:e3.
  • 2Diamanti-Kandarakis E. Insulin resistance in PCDS. Endocrine 2006;30: 13-7.
  • 3Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev 1997; 18:774-800.
  • 4Ho CK, Wood JR, Stewart DR, Ewens K, Ankener W, Wickenheisser J, et al. Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells. J Clin Endocrinol Metab 2005;90:6596-602.
  • 5Li M, Youngren JF, Dunaif A, Goldfine lD, Maddux BA, Zhang BB, et al. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCDS: Effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab 2002;87:4088-93.
  • 6Corbould A, Dunaif A. The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome. Metabolism 2007;56:716-22.
  • 7Manneras-Holm L, Leonhardt H, Kullberg J, Jennische E, Oden A, Holm G, et al, Adipose tissue has aberrant morphology and function in PCDS: Enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab 2011 ;96:E304-11.
  • 8Peppa M, Koliaki C, Nikolopoulos P, Raptis SA. Skeletal muscle insulin resistance in endocrine disease. J Biomed Biotechnol 2010;2010:527850.
  • 9Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 2001 ;52:401-19.
  • 10Carletti MZ, Christenson LK. MicroRNA in the ovary and female reproductive tract. J Anim Sci 2009;87:E29-38.

共引文献29

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部